Implications of Plasma Renin Activity and Plasma Aldosterone Concentration in Critically Ill Patients with Septic Shock by 源��꽭洹� et al.
142
■ Original Article ■
Introduction
High morbidity and mortality from severe sepsis and septic shock  is still an unresolved challenging [1,2]. Sepsis-
induced tissue hypoperfusion and organ dysfunction result from vasodilation, decreased systemic vascular resistance, 
and increased microvascular leakage [3]. Hypotension triggers a complex neurohumoral response during severe sepsis 
to maintain blood pressure homeostasis, resulting in increased sympathetic responses and hypothalamic–pituitary–adre-
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Implications of Plasma Renin Activity and Plasma Aldosterone  
C ncentration in Critically Ill Patients with Septic Shock
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1Division of Pulmonology, Department of Internal Medicine, Institute of Chest Disease, Severance Hospital, Yonsei University College of Medicine, Seoul; 2Division of Pulmonology and 
Critical Care Medicine, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
Background: The renin-angiotensin-aldosterone system is closely associated with volume status and vascular tone in septic shock. 
The present study aimed to assess whether plasma renin activity (PRA) and plasma aldosterone concentration (PAC) measurements 
compared with conventional severity indicators are associated with mortality in patients with septic shock.
Methods: We evaluated 105 patients who were admitted for septic shock. Plasma levels of the biomarkers PRA and PAC, the PAC/PRA 
ratio, C-reactive protein (CRP) level, and cortisol level on days 1, 3, and 7 were serially measured. During the intensive care unit stay, 
relevant clinical information and laboratory results were recorded.
Results: Patients were divided into two groups according to 28-day mortality: survivors (n = 59) and non-survivors (n = 46). The sur-
vivor group showed lower PRA, PAC, Acute Physiologic and Chronic Health Evaluation (APACHE) II score, and Sequential Organ Failure 
Assessment (SOFA) score than did the non-survivor group (all P < 0.05). The SOFA score was positively correlated with PRA (r = 0.373, 
P < 0.001) and PAC (r = 0.316, P = 0.001). According to receiver operating characteristic analysis, the areas under the curve of PRA and 
PAC to predict 28-day mortality were 0.69 (95% confidence interval [CI], 0.58 to 0.79; P = 0.001) and 0.67 (95% CI, 0.56 to 0.77; P = 0.003), 
respectively, similar to the APACHE II scores and SOFA scores. In particular, the group with PRA value ≥3.5 ng ml-1 h-1 on day 1 showed 
significantly greater mortality than did the group with PRA value <3.5 ng ml-1 h-1 (log-rank test, P < 0.001). According to multivariate 
analysis, SOFA score (hazard ratio, 1.11; 95% CI, 1.01 to 1.22), PRA value ≥3.5 ng ml-1 h-1 (hazard ratio, 3.25; 95% CI, 1.60 to 6.60), previ-
ous history of cancer (hazard ratio, 3.44; 95% CI, 1.72 to 6.90), and coronary arterial occlusive disease (hazard ratio, 2.99; 95% CI, 1.26 
to 7.08) were predictors of 28-day mortality.
Conclusions: Elevated PRA is a useful biomarker to stratify the risk of critically ill patients with septic shock and is a prognostic predic-
tor of 28-day mortality.
Key Words: aldosterone; mortality; renin; shock, septic.
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nal axis stimulation [4]. The lack of this response in criti-
cally ill patients is related to a poor prognosis [5,6].
To preserving blood pressure homeostasis, the renin-
angiotensin-aldosterone system (RAAS) is required. By 
loss of blood volume or a drop in blood pressure, RAAS 
induces hormonal activation sequentially with renin-an-
giotensin I-angiotensin II-aldosterone. This sophisticated 
system controls microvascular, blood pressure, and organ 
function [7], as well as inflammatory responses. The dis-
sociation of plasma renin activity (PRA) and aldosterone 
production, namely hyperreninemic hypoaldosteronism, 
has been observed in approximately 20%–30% of criti-
cally ill patients, increasing the development of acute 
renal failure, other organ dysfunction, and death [8]. 
Table 1. Baseline characteristics according to 28-day mortality
Characteristic   Non-survivors (n = 46 [43.8]) Survivors (n = 59 [56.2]) P-value
Age (yr) 65.0 (54.0–73.3) 65.0 (56.0–74.0) 0.824
Male sex 28 (60.9) 37 (62.7) 1.000
APACHE II score 26.0 (23.8–31.0) 22.0 (18.0–28.0) 0.001
SOFA score 9.0 (7.0–12.3) 7.0 (4.0–10.0) 0.001
Comorbidity
CAOD 7 (15.2) 2 (3.4) 0.040
Hypertension 13 (28.3) 28 (47.5) 0.069
Diabetes 10 (21.7) 21 (35.6) 0.137
Heart failure 6 (13.0) 6 (10.2) 0.760
Chronic lung disease 7 (15.2) 11 (18.6) 0.795
Chronic renal disease 6 (13.0) 6 (10.2) 0.760
Chronic liver disease 12 (26.1) 9 (15.3) 0.220
Cancer 35 (76.1) 24 (40.7) <0.001
Primary site of infection 0.814
Pulmonary 34 (73.9) 41 (69.5)
Pancreato-biliary 1 (2.2) 5 (8.5)
Liver 4 (8.7) 3 (5.1)
GI tract 2 (4.3) 3 (5.1)
Soft tissue and bone 1 (2.2) 1 (1.7)
Brain and CSF 0 1 (1.7)
Kidney 1 (2.2) 1 (1.7)
Urogenital 1 (2.2) 3 (5.1)
Miscellaneous 2 (4.3) 1 (1.7)
Positive blood culture 17 (37.0) 18 (30.5) 0.535
Acute renal failure 0.489
At risk 11 (23.9) 15 (25.4)
Injury 9 (19.6) 14 (23.7)
Failure 3 (6.5) 8 (13.6)
Chronic renal disease acute exacerbation, 6 (13.0) 6 (10.2) 0.760
Steroid use within 7 days 29 (63.0) 24 (40.7) 0.031
No. of CRRT applied within 7 days 18 (39.1) 10 (16.9) <0.001
Values are presented as number (%) or median (interquartile range). 
APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; CAOD: coronary arterial occlusive disorder; CSF: cerebrospinal 
fluid; CRRT: continuous renal replacement therapy.
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Plasma aldosterone concentrations (PACs) are useful 
biomarker to detect septic shock patients with a high risk 
of renal dysfunction [8].
However, little is known regarding the usefulness of 
PRA and PAC measurements in prediction of mortality or 
relations with mortality in patients with septic shock. We 
hypothesized that prolonged septic shock increases PRA 
and PACs, resulting in increased inflammatory activity, 
organ failure, and mortality. In this study, we examined 
whether PRA and PAC measurement compared with con-
ventional severity indicators are  associated with 28-day 
mortality in patients with septic shock.
Materials and Methods
1) Study design and setting
This study was a prospective blood sampling and retro-
spective data analysis of a cohort of patients admitted to 
the medical intensive care unit (ICU) from August 2008 
to January 2009. We enrolled 140 patients aged older 
than 19 years who had been admitted to the ICU with 
septic shock from August 2008 to January 2009. All of 
the patients met the following criteria for septic shock, 
as established by the International Sepsis Definitions 
Conference [9]: (1) clinical diagnosis of septic shock made 
within the past 48 hours with a documented bacterial infec-
tion and (2) at least two of the following: fever (body tem-
perature, >38°C) or hypothermia (<36°C), heart rate >90 
beats min-1, respiratory rate >20 breaths min-1, white blood 
cell count >12,000 cells mm-3 or <4,000 cells mm-3, or >10% 
immature (band) forms. Patients also had to meet the ad-
ditional following criteria for septic shock: the presence 
of at least two signs of organ dysfunction (metabolic aci-
dosis, arterial hypoxemia [PaO2/FiO2 ratio <250], oligu-
ria [<30 ml kg-1 for 3 hours], intravascular disseminated 
coagulopathy, or an abrupt change in mental status); 
and persistent hypotension with systolic blood pres-
sure of <90 mmHg for at least 1 hour, despite adequate 
fluid replacement (assessed by a central venous pressure 
>8 mmHg) and continuous administration of inotropic or 
vasopressor support [9].
Figure 1. Flow chart of inclusion 
and exclusion of patients in the 
study. A total of 140 patients were 
enrolled between August and De-
cember 2008, and 105 patients 
were included in the analysis. 
Patients without available renin 
and aldosterone measurements (n 
= 2), those using an angiotensin-
converting enzyme (ACE) inhibitor 
or angiotensin receptor blocker 
(ARB) (n = 12), those using an al-
dosterone antagonist (n = 5), those 
using steroids (≥15 mg/d) (n = 12), 
and those who had previous usual 
hemodialysis (n = 4) within 7 days 
were excluded. ICU: intensive care 
unit. 
140 Total patients with septic shock 
admitted to ICU 
from August to December 2008
2 No available renin and aldosterone  
measurement
   Exclusion
   - 12 ACE inhibitor or ARB use
   - 5 Aldosterone antagonist use
   - 12 Steroids use
   - 4 Usual hemodialysis
105 Patients analyzed
46 Patients 
28-day non-survivors 
59 Patients 
28-day survivors
138 ICU patients 
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We excluded two patients without PAC or PRA mea-
surements. We also excluded 33 patients who had previ-
ously taken angiotensin-converting enzyme inhibitors or 
angiotensin receptor blockers (n = 12), who previously 
took aldosterone antagonists (n = 5), who had a history 
of steroid usage (n = 12), and who had previously used 
hemodialysis (n = 4). A total of 105 patients were includ-
ed in the study. Demographic, clinical, and biochemical 
data at the time of ICU admission were recorded. Base-
line characteristics are shown in Table 1 and Figure 1.
2) Data collection
To assess the severity of illness and prognosis of the 
underlying disease, the Acute Physiology and Chronic 
Health Evaluation (APACHE) II score and Sequential 
Organ Failure Assessment (SOFA) score were evaluated 
at the initial time of ICU admission. The SOFA score was 
also recorded on days 1, 3, and 7. Data of the following 
parameters were also collected: age, sex, total fluid input 
and output, serum creatinine levels, arterial blood gas 
analysis, and serum electrolytes. Additionally, patients 
were assessed with respect to their need for mechanical 
ventilation, ventilator-free days, and/or renal replacement 
therapy. All of the patients were evaluated over their 
entire ICU stay, and ICU-free days and outcomes were 
recorded. The definitions of ventilator free-days and ICU 
free-days are as follows:
Ventilator free-days = number of days from day 1 to 
day 28 on which a patient breathed without assistance (if 
the period of unassisted breathing lasted at least 48 con-
secutive hours)
ICU free-days = number of days from day 1 to day 28 
on which a survived patient is not in ICU
3) Plasma biomarker sampling
Blood samples were collected with the patient in the su-
pine position in the early morning. On the day of sampling, 
blood samples were immediately sent to a laboratory for 
measuring biomarkers, such as PACs (by radioimmunoas-
say; normal range, 29.9 to 158.8 ng dl-1; Cobra II gamma 
counter, Hewlett-Packard, Meriden City, KS, USA), 
PRA (by radioimmunoassay; normal range, 0.15 to 2.23 
ng ml-1 h-1; Cobra II gamma counter, Hewlett-Packard), 
plasma cortisol levels (by comparative binding immuno-
enzymatic assay; normal range, 6.7 to 22.6 pg ml-1; UNICEL 
DXI 800, Beckman Coulter Inc., Brea, CA, USA), and 
C-reactive protein (CRP) levels (by immunoturbidime-
try; normal range, 0 to 8.0 mg L-1; Hitachi 7600, Sekisui, 
Japan). Serial PACs, PRA, the PAC/PRA ratio, cortisol 
levels, and CRP levels were measured on days 1, 3, and 
7 to analyze changes over time. Based on the previous 
study, the definition of hyperreninemic hypoaldosteron-
ism was defined when PAC/PRA ratio was less than 2 [8].
4) Statistical analyses
Continuous variables are presented as the mean ± 
standard deviation or median (interquartile range) and 
categorical variables as number (percentage) of the total 
sample. Baseline characteristics of the groups were com-
pared using the χ2 test or Fisher exact test for categorical 
variables. And nonnormally distributed variables were 
compared using the Mann-Whitney U-test, and normally 
distributed variables using Student t-test when analyzing 
continuous variables. Pearson correlation was performed 
to investigate the relationships between SOFA scores and 
PRA or PACs. We evaluated 28-day all-cause mortality 
as the study endpoint. We conducted receiver operating 
characteristic (ROC) analysis to compare the predic-
tive accuracy of PRA or PACs and APACHE II scores 
or SOFA scores. The area under the curve (AUC) was 
calculated. The Youden index was used to determine the 
optimal cutoff value of PRA or PACs for predicting 28-
day mortality. Survival curves were prepared using the 
Kaplan-Meier method, and comparisons were made using 
the log-rank test. Prognostic variables for mortality were 
analyzed using the univariate Cox proportional hazards 
model, and variables with P-values <0.1 were used in the 
multivariate Cox proportional hazard model with back-
ward selection. Results of univariate and multivariate Cox 
regression analyses are presented as hazard ratios and 
95% confidence intervals (CIs). Differences were consid-
ered statistically significant at P < 0.05 (two-tailed). Sta-
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tistical analyses were performed using the SPSS software 
package version 18.0 (SPSS Inc., Chicago, IL, USA).
5) Ethics statement
The protocol was approved by our institutional review 
board (No. 4-2008-0099). Written informed consent was 
obtained from the patients or their next of kin.
Results
1) Baseline characteristics of the study population 
A total of 105 patients with septic shock were enrolled. 
There were 65 (61.9%) men and 40 (38.1%) women. The 
mean age was 63.6 years (range, 55 to 74 years). The 28-
day mortality was 43.8% (n = 46) and these patients were 
classified as non-survivors. The remaining patients were 
classified as survivors. Table 1 shows the comparison of 
demographics and clinical parameters on day 1 between 
non-survivors and survivors. Age, sex, primary infection 
site, the rate of positive blood culture, the comorbidities 
are similar in both groups. However, the survivor group 
showed lower APACHE II scores (P = 0.001) and SOFA 
scores (P = 0.001), and a much more prevalent history 
of coronary arterial occlusive disease or cancer than did 
the non-survivor group. In terms of critical care needs, 
patients in the non-survivor group had less ventilator-free 
days (P < 0.001) and ICU-free days (P < 0.001), and re-
quired a higher number of steroid use and continuous re-
nal replacement therapy applications within 7 days after 
admission than did those in the non-survivor group. The 
non-survivor group showed a higher heart rate (P = 0.036) 
Table 2. Clinical and biological characteristics according to 28-day mortality
Variable Non-survivor (n = 46 [43.8]) Survivor (n = 59 [56.2]) P-value
Mechanical ventilation used 43 (93.5) 49 (83.1) 0.140
Heart rate (beats min-1) 120.0 (90.5–136.5) 105.0 (81.0–126.0) 0.036
Mean arterial pressure (mmHg) 69.2 (62.8–92.6) 79.0 (65.7–99.3) 0.129
pH 7.4 (7.3–7.5) 7.4 (7.3–7.5) 0.395
PaCO2 (mmHg) 35.7 (29.5–41.0) 32.2 (27.4–36.6) 0.320
P/F ratio 197.7 (150.7–257.9) 264.6 (180.5–365.5) 0.002
PEEP (cmH2O) 10.0 (8.0–12.0) 10.0 (6.0–12.0) 0.679
Platelet (103/µl ) 128.0 (52.5–227.8) 159 (76.0–314.0) 0.278
Serum potassium (mmol L-1) 3.8 (3.4–4.6) 3.7 (3.3–4.1) 0.301
Serum sodium (mmol L-1) 137.0 (134.8–144.0) 138.0 (134.0–142.0) 0.279
Blood urea nitrogen (mg dl-1) 24.7 (16.2–40.1) 25.6 (15.6–41.0) 0.853
Serum creatinine (µmol L-1) 1.3 (0.7–1.9) 1.2 (0.9–2.2) 0.760
Ejection fraction (%) 66.0 (54.0–70.0) 66.0 (60.0–70.0) 0.551
Net fluid balance at 1 days (L) 2.0 (0.5–3.4) 1.0 (0.2–2.3) 0.022
Blood Biomarkers
CRP (mg L-1) 14.3 (5.8–28.7) 13.8 (8.3–23.3) 0.578
Cortisol (pg ml-1) 23.8 (15.2–46.0) 25.0 (15.8–45.3) 0.210
PRA (ng ml-1h-1) 8.7 (3.2–23.4) 2.4 (0.7–7.9) 0.003
PAC (ng dl-1) 125.9 (37.0–255.9) 53.8 (23.0–135.7) 0.008
PAC/PRA ratio 1.2 (0.6–3.0) 1.9 (0.7–5.9) 0.581
PAC/PRA <2 23 (50.0) 35 (59.3) 0.429
Values are presented  as number (%) or median (interquartile range).
P/F: PaO2/FIO2; PEEP: positive end-expiratory pressure; CRP: C-reactive protein; PRA: plasma renin activity; PAC: plasma aldosterone concentration.
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and net fluid balance on day 1 (P = 0.022), but a lower 
PaO2/FiO2 ratio (P = 0.002), than did the survivor group. 
The survivor group showed significantly lower PRA (P = 
0.003) and PACs (P = 0.008) than did the non-survivor 
group. However, there were no significant differences in 
other blood biomarkers, such as CRP levels, cortisol lev-
els, and the PAC/PRA ratio, between the non-survivor and 
survivor groups (Tables 1 and 2).
2)		Time	course	of	PRA	and	PACs	during	the	first	7	ICU	
days in the non-survivor and survivor groups
The time course of PRA in he survivors and non-survi-
vors was as follows. PRA and PACs in the survivors were 
significantly lower than in the non-survivors on days 1, 
3, and 7 (Figure 2, Supplementary Table 1). PACs were 
significantly lower in the survivor group than in the non-
survivor group on days 1 (P = 0.008), 3 (P = 0.001), and 
7 (P = 0.012). CRP levels, cortisol levels, and the PAC/
PRA ratio were not different between the non-survivor 
and survivor groups on day 1, 3, and 7 (Supplementary 
Table 1). When serial PAC, PRA, cortisol, and CRP level 
were measured, PAC and PRA level were consistently 
lower in the surviving group, but CRP and cortisol level 
were not (Supplementary Table 1).
3)		Correlations	between	PRA	or	PACs	and	the	APACHE	II	
score and SOFA score
PRA was positively correlated with the APACHE II 
score (r = 0.230, P = 0.018) and the SOFA score (r = 
0.373, P < 0.001) (Figure 3A and B). PACs were only 
positively correlated with the SOFA score (r = 0.316, P 
= 0.001) (Figure 3C and D). However, both biomarkers 
showed weak positive correlation.
4) Risk analysis for 28-day mortality
The areas under the ROC curve for PRA and PAC val-
ues on day 1 were 0.69 (95% CI, 0.58 to 0.79; P = 0.001) 
and 0.67 (95% CI, 0.56 to 0.77; P = 0.003), respectively. 
These values were similar to the APACHE II scores (AUC, 
0.68; 95% CI, 0.58 to 0.78; P = 0.001) and SOFA scores 
(AUC, 0.67; 95% CI, 0.57 to 0.77; P = 0.003) (Figure 4). 
Therefore, based on the maximal value of the Youden 
index (J = 0.25), the most discriminatory markers were 
PRA with a cutoff of 3.5 ng ml-1 h-1 (sensitivity of 76.1% 
and specificity of 64.4%) and PAC with a cutoff of 112 
ng dl-1 (sensitivity of 58.7% and specificity of 71.2%) for 
Figure 2. Time courses of PRA and PACs in non-survivors versus survivors. Levels of PRA (A) and PACs (B) were measured on days 
1, 3, and 7 after admission. The circles and bars indicate the mean values and SEM, respectively. Significant differences between non-
survivors and survivors are indicated by an asterisk (*P < 0.05, survivors versus non-survivors on each day). PRA: plasma renin activ-
ity; PAC: plasma aldosterone concentration; SEM: standard error of the mean. 
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predicting 28-day mortality. Kaplan-Meier survival analy-
sis showed that the 28-day mortality of patients with PRA 
values ≥3.5 ng ml-1 h-1 (n = 49) was higher than that of 
patients with PRA values <3.5 ng ml-1 h-1 (n = 56) (log-rank 
test, P < 0.001, Figure 5). Using Cox regression analysis, 
PRA and PACs, as well as several other clinical character-
istics to predict 28-day mortality, were evaluated (Table 3). 
After adjusting for confounding factors, the SOFA score 
(hazard ratio, 1.11; 95% CI, 1.01 to 1.22), PRA values 
≥3.5 ng ml-1 h-1 (hazard ratio, 3.25; 95% CI, 1.60 to 6.60), 
previous history of cancer (hazard ratio, 3.44; 95% CI, 1.72 
to 6.90) and coronary arterial occlusive disease (hazard 
ratio, 2.99; 95% CI, 1.26 to 7.08) were independently as-
sociated with 28-day mortality.
Discussion
In the current study, we assessed clinical parameters, 
including serial serum PRA and PACs of septic shock 
patients on days 1, 3, and 7 after admission to ICU in 
a single-center cohort. The main findings of this study 
were as follows: (1) 28-day survivors showed lower PRA 
and PAC values than did 28-day non-survivors; (2) PRA 
and PACs were positively correlated with severity scores; 
and (3) in particular, patients with septic shock with PRA 
Figure 3. Correlations between PRA or PAC, SOFA score, and APACHE II score on day 1. The PRA levels correlated with better with 
APACHE II score (A) or SOFA score (B) than the PAC levels (C, D) although there were weak correlations. The open circles indicate sur-
vivors, and the solid circles indicate non-survivors. APACHE: Acute Physiologic and Chronic Health Evaluation; PRA: plasma renin activ-
ity; SOFA: Sequential Organ Failure Assessment; PAC: plasma aldosterone concentration. 
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values ≥3.5 ng ml-1 h-1 on day 1 were related to 28-day 
mortality. 
APACHE II score or SOFA score are used as a good 
indicator of the severity stratification or prognosis predi-
cation of patients with sepsis in the ICU. In our study, 
PRA and PACs were positively correlated with the SOFA 
score on days 1, 3, and 7. Their prognostic accuracy was 
similar to that of SOFA scores for mortality. PRA values 
≥3.5 ng ml-1h-1 on day 1 was identified as an independent 
factor associated with 28-day mortality, even after adjust-
ing for other parameters and severity scores (APACHE 
II and SOFA score). Although a single biomarker can-
not substitute a composite indicator of severity such as 
APACHE II score or SOFA score, our findings may help 
to understand the pathophysiology in septic shock. And 
these results could be explained as follows. Over the 
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Figure 5. Kaplan-Meier survival curves for 28 days according to 
PRA. The cutoff value was the optimal cutoff limit that predicted 
28-day mortality (PRA <3.5 ng/ml/h or ≥3.5 ng/ml/h). PRA: 
plasma renin activity; ICU: intensive care unit. 
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Figure 4. Receiver operating characteristic curves for PRA and 
PAC on day 1 for predicting 28-day mortality. The prognostic 
accuracy of PRA and PAC was not inferior to that of the APACHE 
II and SOFA scores. APACHE: Acute Physiologic and Chronic 
Health Evaluation; AUC: area under the curve; CI: confidence in-
terval; SOFA: Sequential Organ Failure Assessment; PRA: plasma 
renin activity; PAC: plasma aldosterone concentration.
Table 3. Univariate and multivariate Cox model for 28-day mortality in patients with septic shock
Covariable
Univariate analysis Multivariate analysis
HR 95% CI P-value HR 95% CI P-value
APACHE II score 1.073 1.028–1.121 0.001
SOFA score 1.169 1.082–1.263 <0.001 1.112 1.011–1.224 0.029
Previous cancer history 3.140 1.591–6.197 0.001 3.442 1.717–6.899 <0.001
CAOD history 2.645 1.179–5.935 0.018 2.989 1.263–7.075 0.013
Steroid use within 7 days 1.945 1.068–3.542 0.030
CRRT within 7 days 2.290 1.265–4.147 0.006 1.769 0.924–3.385 0.085
Heart rate 1.011 1.000–1.022 0.048
Net fluid balance at day 1 1.000 1.000–1.000 0.011
PaO2/FIO2 ratio 0.998 0.995–1.001 0.130
PRA ≥3.5 ng/ml/h 3.943 1.996–7.790 <0.001 3.245 1.596–6.597 0.001
PAC ≥112 ng/dl 2.642 1.466–4.760 0.001
HR: hazard ratio; CI: confidence interval; APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; CAOD: coronary artery 
obstructive disease; CRRT: continuous renal replacement therapy; PRA: plasma renin activity; PAC: plasma aldosterone concentration.
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last decade, new components of the RAAS have been 
found to be involved in many essential pathophysiologi-
cal processes, such as development, inflammation, and 
remodeling [10,11]. Recently, the relevance between the 
potentially proinflammatory effects of angiotensin II and 
the pathogenesis of sepsis and acute lung injury has been 
of interest [12-14]. Blocking of a pro-renin receptor at-
tenuates an inflammatory response in an animal model of 
sepsis using rat [15]. Many serum markers in the inflam-
matory cascade have been assessed in sepsis as potential 
indicators of infection [16]. In particular, the RAAS 
plays important roles in controlling blood pressure, mi-
crovascular regulation, and organ function, as well as in 
inflammatory responses. In our study, there was a posi-
tive linear correlation between PRA or PACs and the 
organ failure score (SOFA score) in septic shock patients. 
We initially expected that elevated PRA or PACs may 
also contribute to a stronger inflammatory response and 
may be a similarly useful prognostic indicator as serial 
CRP measurements in prediction of infection [17] and in 
monitoring treatment responses [18-20]. However, there 
was no linear correlation between PRA or PACs and CRP 
levels. Further studies are required to determine the role 
of PRA and PACs in the inflammatory response using 
other inflammatory markers.
This was the first study to elucidate the relationship 
between PRA and mortality in patients with septic shock. 
There have been no studies on the association between 
PRA and mortality in patients with septic shock. How-
ever, in animal experiments, there is evidence between 
RAAS activity and sepsis [11]. In some studies, hyper-
reninemic hypoaldosteronism has been identified as a po-
tential prognostic indicator of septic shock-induced acute 
renal failure [8] and liver cirrhosis [21]. du Cheyron et 
al. [8] showed that hyperreninemic hypoaldosteronism 
might be related with acute kidney injury in patients with 
septic shock. In our study, 55.2% of patients with septic 
shock had hyperreninemic hypoaldosteronism. du Chey-
ron et al. [8] found hyperreninemic hypoaldosteronism 
in 48% of septic shock patients, which is similar to our 
study. However, we did not find any correlations between 
hyperreninemic hypoaldosteronism and any clinical out-
come, such as renal failure, ventilator-free days, ICU-
free days, and 28-day mortality (data not shown). Similar 
to our study, du Cheyron et al. [8] also found that patients 
with septic shock showed markedly elevated PRA levels, 
associated with volume depletion and catecholamine-in-
duced stimulation of β-adrenergic receptors. In our study, 
the non-survivor group showed higher PRA and PACs 
than did the survivor group, despite a greater net fluid 
balance on day 1. This finding suggests that patients with 
higher PRA and PACs need much more fluid administra-
tion for intravascular volume depletion than expected. 
In our data, PRA was consistently higher in non-survival 
group (Figure 2A). Therefore, mortality in septic shock 
patients may be relevant with prolonged plasma renin 
activation not merely hyperreninemic hypoaldosteronism 
defined as a fixed cutoff (PAC/PRA <2).
The effects of the RAAS are no longer considered to be 
limited to the circulatory system. This is because system 
components are also produced and activated in situ in 
other tissues, including the brain, blood vessels, adre-
nals, adipose tissue, kidney, and heart, acting through 
paracrine and autocrine mechanisms [22]. In particular, 
angiotensin II can promote cell growth and inflammation 
by enhancing expression of endothelium-derived adhe-
sion molecules [23] and production of pro-inflammatory 
cytokines and chemokines [24]. Angiotensin II also has 
procoagulant activity [25], and can stimulate reactive 
oxygen species production [26]. This results in increased 
microvascular hydraulic permeability [27] and capillary 
leakage in severe sepsis. Doerschug et al. [7] showed 
that PRA was correlated with plasma concentrations of 
angiotensin II, microvascular dysregulation, and organ 
failure in patients with septic shock. Accordingly, long-
term RAAS over-activation may be harmful in patients 
with severe sepsis and septic shock, regardless of hyper-
reninemic hypoaldosteronism. In our serial follow-up 
data (day 1, day 3, and day 7), consistently high PRA 
levels were observed in non-survivor groups. And we 
found the relation between high PRA level and mortal-
ity in septic shock in Cox regression model. Therefore 
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we support a negative effect on survival in septic shock 
patients by long-term RAAS over-activation. Hirano et 
al. [15] showed that a (pro) renin receptor blocker sig-
nificantly improved survival in rats with clinically rel-
evant sepsis induced through cecal ligation and puncture. 
However, further human data on RAAS activity in sepsis 
are required. In a practical situation, it may be important 
to identify the appropriate time and subject to receive a 
RAAS antagonist because of the beneficial role of angio-
tensin II in maintaining vascular tone during septic shock. 
Our study showed that renin activity ≥3.5 ng ml-1 h-1 was 
significantly correlated with 28-day mortality in patients 
with septic shock. This finding can be used as the basis 
for selection of (pro) renin blocker candidates for future 
clinical studies. Interestingly, Vergaro et al. [28] showed 
that a cutoff value for PRA ≥2.3 ng ml-1 h-1 was the best 
predictor of cardiac mortality in patients with heart fail-
ure, which is similar to our finding. In future studies, 
cutoff values for PRA should be investigated in various 
diseases.
We are aware of some limitations of our research. 
First, this small, single-center, retrospective cohort study 
should not be generalized. Large-scale, multicenter, pro-
spective validation studies are required to confirm these 
findings. Although this was a retrospective cohort study, 
we attempted to remove confounding factors from the 
data, such as prior use of angiotensin-converting enzyme 
inhibitors, angiotensin receptor blockers, aldosterone 
antagonists, and steroids, as well as the effect of terminal 
renal failure. Second, we did not perform adrenocortico-
tropic hormone stimulation tests to assess the adequacy 
of adrenal function. This is a major limitation, even 
though an adrenocorticotropic hormone stimulation test 
is usually not recommended in patients with septic shock 
[29]. In addition, no data about thyroid function test can 
affect the results of our study. Third, we did not examine 
plasma angiotensin II concentrations because angiotensin 
II are not correlated with SOFA score in the later course 
of sepsis [7]. Additionally, a previous study showed that 
angiotensin II activity is only correlated with organ fail-
ure only during initial treatment. However, we wished to 
evaluate PRA and PACs over the course of septic shock. 
Fourth, in this study, the ROC AUC of APACHE II and 
SOFA score were relatively low because it may be due to 
the difference in the timing of beginning of septic shock 
and the time of admission to the ICU. And elevated PRA 
levels cannot be generalized to the entire sepsis patients 
because our study was aimed only at patients with septic 
shock. These points required careful interpretation. Fi-
nally, we only assessed CRP as an inflammatory marker 
with PRA and PACs. We did not measure blood lactate 
levels, procalcitonin, or prothrombin time for inflamma-
tion or coagulation system. Other biomarkers may show 
different results. 
In conclusion, based on our findings, elevated PRA might 
be a useful prognostic biomarker for risk stratification of 
patients with septic shock, and an indicator of 28-day mor-
tality. Therefore, the results of our study support that PRA 
can be a potential therapeutic target. In the future, mul-
ticenter, large-scale studies on RAAS inhibition, such as 
PRA antagonists may be needed for septic shock treatment.
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